Medicamen Biotech Limited (BOM:531146)
India flag India · Delayed Price · Currency is INR
303.00
+5.50 (1.85%)
At close: Mar 4, 2026

Medicamen Biotech Revenue

Medicamen Biotech had revenue of 474.43M INR in the quarter ending December 31, 2025, with 5.10% growth. This brings the company's revenue in the last twelve months to 1.72B, down -4.52% year-over-year. In the fiscal year ending March 31, 2025, Medicamen Biotech had annual revenue of 1.68B, down -6.56%.

Revenue (ttm)
1.72B
Revenue Growth
-4.52%
P/S Ratio
2.18
Revenue / Employee
4.58M
Employees
376
Market Cap
3.75B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251.68B-117.59M-6.56%
Mar 31, 20241.79B384.39M27.29%
Mar 31, 20231.41B254.22M22.02%
Mar 31, 20221.15B27.29M2.42%
Mar 31, 20211.13B-128.18M-10.21%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition